Drug recall D-1518-2016
Product
Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp. Date
Lots and codes
Lot # 5RZ002; Exp. 04/18
Recall details
- Recalling firm
- Genzyme Corporation / Genzyme Biosurgery, Ridgefield, NJ
- Quantity
- 9,530 vials
- Distribution
- nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 4, 2016
- Terminated
- April 19, 2018
Related products
- Mozobil – drug information
- NDC 0024-5862 Mozobil · Plerixafor 24 mg/1.2mL · Sanofi-Aventis U.S. LLC